Moderna Facts

 

FOUNDING YEAR:

2010

 

TEAM MEMBERS:

650+

Current Job Openings >

HEADQUARTERS:

Cambridge, MA

CEO:

Stéphane Bancel

Learn About Stéphane >

 

LOCATIONS:

200 Technology Square, Cambridge, MA

500 Technology Square, Cambridge, MA

One Upland Road, Norwood, MA

SPACE:

200,000 Sq Ft (R&D, New Venture Labs, automated production & GMP clinical supply manufacturing)

200,000 Sq Ft GMP mRNA clinical manufacturing facility in Norwood, MA

THERAPEUTIC AREAS: 

  • Infectious Diseases
  • Immuno-Oncology
  • Rare Diseases

CAPITALIZATION:

  • Cash on Balance Sheet: $1.23 Billion (As of September 30, 2018)
  • Total Cash Raised (Financing & Partners): $2.4B
  • Potential $250M in Grants: Bill & Melinda Gates Foundation, BARDA & DARPA
  • No Debt

PARTNERS:

PIPELINE:

  • 21 Development Candidates
  • 10 Clinical Programs

View Our Pipeline >

INVESTORS:

  • Venture Investor: 
    Flagship Pioneering >
  • Institutional Investors: Viking, Invus, RA Capital, Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius Baer, EDBI Sequoia Capital China, Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners, Alexandria Venture Investment, and others in U.S., Europe & Asia
  • Our partners — AstraZeneca, Merck & Vertex — are also investors

Last Updated:  November 2018